APUS Stock Price Chart
APUS Earnings
Apimeds Pharmaceuticals US Inc
$0
0%
$0
At close: Jun 26, 16:00:00 GMT-4
$0
0%
$0
Post-market: Jun 26, 18:31:11 GMT-4
Back
Apimeds Pharmaceuticals US Inc (APUS) Earnings
Key Stats
Prev.Close
--
Open
--
Day's Range
-
52 week range
-
Volume
--
Avg.Volume
--
Dividend yield
--
EPS (TTM)
--
Market Cap
--
What is APUS?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
